Vital research findings pointing to improved treatment for children with Group 3 medulloblastoma brain tumors have been revealed in two major studies published in the journal Neuro-Oncology.
Edg Adrian A. Eva, Reporter Hearing loss for children receiving cancer treatment is a difficult side effect—particularly during their formative years, when connecting with society is crucial to their ...